TX-HEWLETT-PACKARD
18.5.2021 13:02:29 CEST | Business Wire | Press release
Hewlett Packard Enterprise (NYSE: HPE) today announced solutions to help organizations advance data monetization by tapping into Gaia-X , an emerging federated data infrastructure supported by more than 300 organizations in Europe and globally.
The HPE Solution Framework for Gaia-X was designed for companies, service providers and public organizations that want to get ready to participate in Gaia-X. It supports virtually all capabilities that are required to both provide and consume data and services in a decentralized, federated environment. As a result, organizations can advance their ability to create value from data, tap into huge distributed data pools, and strengthen their sovereignty over their data-driven business model.
The framework is based on a reference architecture, leveraging key components of HPE’s software portfolio, third-party software, and the Cloud28+ business platform, a marketplace for the monetization of data and services. Individual solution components and entire solution environments are available as a service via HPE GreenLake cloud services.
HPE also announced the HPE Roadmap Service for Gaia-X which helps customers assess their Gaia-X readiness and develop a roadmap.
“Gaia-X is an answer to the key question of the next wave of digital transformation: How can we create network effects without centralizing all the data? This is perfectly in line with our company strategy which is focused on unlocking the value of data distributed across locations and clouds,” says Johannes Koch, Senior Vice President, Germany, Austria and Switzerland, HPE. “However, Gaia-X does not do the job alone. It requires a range of capabilities to benefit from this platform. In essence, you must know how to monetize data and put it to work. That’s exactly what we help customers achieve with our Gaia-X solutions.”
New era of decentralized data to drive economic and social progress
The European Commission has declared data value creation to be the crucial source of economic and social progress in the next decades. This will be driven by a “new wave” of industrial and professional data, with 80 percent of the overall data volume to be processed in a decentralized manner by 2025.
According to the World Economic Forum , this enables organizations to create “value from data insights” in the form of new revenue streams, new business models, better customer experiences, and better decisions. As an example, McKinsey estimates that the monetization of connected-car data could deliver $250 billion to $400 billion in annual incremental value for players across the mobility ecosystem in 2030. And the European Union’s data economy is forecasted to almost triple between 2018 and 2025 to reach a value of 829 billion Euros.
A radically new approach for sovereign data value creation
However, it’s not certain to which extent organizations will be able to actually materialize these opportunities. According to a global report by IDC and Seagate , only 32 percent of data available to enterprises are put to work. Moreover, according to the European Commission , “currently a small number of big tech firms hold a large part of the world’s data. This could reduce the incentives for data-driven businesses to emerge, grow and innovate.”
Decentralized cloud and data infrastructures take a radically new approach to address that challenge. They enable sharing and aggregation of data, insights, and services at scale without a central intermediary. This creates a level playing field, with power and opportunities distributed across all parties.
Gaia-X is emerging as a focal point of this endeavor. Gaia-X connects centralized and decentralized infrastructures to strengthen the ability to both access and share data securely and confidently. Gaia-X is now entering its operational phase with first flagship projects, and first Gaia-X-compliant solutions are expected to be certified in December 2021 .
HPE is supporting customers to get ready for Gaia-X
HPE is a day-1 member of the non-profit organization Gaia-X AISBL and contributes to the Gaia-X architecture, standards, and certification. HPE is already working with dozens of organizations across Europe to help them get ready for decentralized data infrastructures such as Gaia-X.
One of them is Orange Business Services , a European network-native digital services provider supporting customers worldwide to bring the best innovations with the strongest data protections. “We are helping shape the technical and dataspace foundations of the Gaia-X ecosystem, and we are currently adapting Orange Cloud services to these specifications in order to continue providing the most trusted cloud solutions to our customers within Gaia-X,” says Cedric Parent, Deputy CEO, Orange Cloud. “HPE is a key partner to power Orange Cloud platforms with state-of-the-art technology and capabilities. We benefit from HPE’s deep expertise and solution offering, which comprehensively support the developments needed to fully benefit from decentralized infrastructures such as Gaia-X.”
CSC - IT Center for Science Ltd , the Finnish organization hosting Europe‘s first pre-exascale supercomputer named LUMI , is currently preparing to make supercomputing available as part of an ecosystem of capabilities, where Gaia-X will play a major role. “We are working with HPE to provide trustworthy, secure and efficient supercomputing for research and industry. CSC is happy to provide its solid expertise in handling sensitive data, e.g. for the purposes of health research,” says Pekka Manninen, Director, LUMI Leadership Computing Facility, CSC.
Solution framework for Gaia-X readiness
A central element of the HPE Solution Framework for Gaia-X is a reference architecture that defines the foundation of the components necessary to build Gaia-X use cases. It ensures secure infrastructure operation for decentralized workloads and includes a central governance structure.
The technological foundation is the HPE Ezmeral Software Platform which provides capabilities such as unified access to distributed data and unified control of distributed Kubernetes clusters. HPE also leverages SPIFFE , the Secure Production Identity Framework For Everyone, and SPIRE , the SPIFFE Runtime Environment – open-source standards for securely authenticating software services through the use of platform-agnostic, cryptographic identities.
The Cloud28+ business platform enables customers to leverage and monetize their data and services via a marketplace. This platform was originally created as the service catalogue of the Cloud28+ community, and it’s now available to be used by individual organizations, in addition to HPE’s partner network.
An active contributor to the Gaia-X architecture and standards, HPE will equip its solution framework with the required interfaces, connectors and services so customers can seamlessly connect to the Gaia-X platform and ecosystem.
Availability
The HPE Solution Framework for Gaia-X and the HPE Roadmap Service for Gaia-X are available in Europe. Individual solution components and entire solution environments are available via HPE GreenLake cloud services. Gaia-X interfaces and connectors will be made available as soon as Gaia-X specifications are final.
About Hewlett Packard Enterprise
Hewlett Packard Enterprise is the global edge-to-cloud platform as-a-service company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions, with a consistent experience across all clouds and edges, to help customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005050/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
